Key Record Dates
ClinicalTrials.gov Identifier: | NCT03245151 |
---|---|
Brief Title: | Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors |
First Submitted : | August 3, 2017 |
First Submitted that Met QC Criteria : | August 7, 2017 |
First Posted : | August 10, 2017 |
Results First Submitted : | August 7, 2023 |
Results First Submitted that Met QC Criteria : | August 7, 2023 |
Results First Posted : | August 30, 2023 |
Last Update Submitted that Met QC Criteria : | August 7, 2023 |
Last Update Posted : | August 30, 2023 |